Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature.
Adv Ther
; 37(8): 3450-3462, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-648906
ABSTRACT
The COVID-19 outbreak was declared a pandemic on March 2020. Many patients with SARS-CoV-2 infection have underlying chronic medical conditions such as diabetes, cardiovascular disease (CVD), and hypertension. Patient-related outcomes are worse if there are associated comorbidities. We do not have enough evidence regarding the most appropriate management of patients with diabetes during COVID-19 infection. Insulin resistance and CVD together increase the inflammatory state of the body, which can contribute to and perhaps mediate the increase of COVID-19 severity. Hence, in addition to management of dysglycemia, other CVD risk factors should be targeted. We explore the possible pathophysiologic links between diabetes and COVID-19 and discuss various options to treat dysglycemia, hypertension, and dyslipidemia in the era of COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Cardiovascular Diseases
/
Coronavirus Infections
/
Diabetes Mellitus
/
Dyslipidemias
/
Pandemics
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Adv Ther
Journal subject:
Therapeutics
Year:
2020
Document Type:
Article
Affiliation country:
S12325-020-01417-8
Similar
MEDLINE
...
LILACS
LIS